Meraco Logo
MERACOUnified Pharmaceutical Intelligence
Iraq's #1 Pharma Telemetry Platform

See the entire Iraqi pharma market in one dashboard

Real-time sales velocity, market share analytics, AI-powered geo-targeting, and gross margin auditing — covering 5,747 active medications across 18 governorates.

M
S
P
Trusted by 50+ scientific offices and manufacturers across Iraq to monitor market share.

0

Active Medications

Tracked in real-time

4,700+

Connected Terminals

Systems online

18

Iraqi Governorates

Full national coverage

50+

Trusted Partners

Scientific offices & factories

HIPAA Compliant
End-to-End Encrypted
Zero Raw Data Exposure
Role-Based Access Control
Payment Analytics
Platform Capabilities

Everything you need to dominate the market

Six integrated intelligence modules working together to give you an unfair competitive advantage in the Iraqi pharmaceutical landscape.

Market Overview & KPIs

National sales volume, growth indices, average pack rates, and quarterly trend lines updated from live POS telemetry across all 18 governorates.

Market Share Analytics

Manufacturer classification (Local vs Global), therapeutic sub-class breakdowns (DPP-IV, GLP-1, SGLT2), and competitive brand positioning with real market data.

Governorate Sales Breakdown

Granular sales volume, velocity, and revenue share tracking across all 18 governorates. Identify and compare regional demand patterns.

Financial Margin Auditing

Gross margin calculations, procurement cost tracking, payment structure analysis (Cash 72.4% vs Card 27.6%), and Q1-Q2 2026 revenue breakdowns.

AI Drug Normalizer

Intelligent entity resolution engine that normalizes messy POS entries into canonical drug profiles using fuzzy bigram matching with 95%+ accuracy.

Live Terminal Feed

Real-time transaction stream from connected pharmacy systems with automated anomaly detection, sync status, and velocity logging.

Interactive Preview

See what's inside the dashboard

Explore real data previews from each module. This is exactly what subscribers see after authentication.

Total Q1-Q2 Volume

148,930

+42%

+42% YoY growth

National Market Value

$42.8M

+12.4%

Gross revenue estimate

Growth Index

1.42x

Accelerating

vs. same period 2025

Average Pack Rate

14,200 IQD

Stable

Weighted national avg

Monthly Sales Velocity (Jan — Jun 2026) Upward Trend
22K
Jan
28K
Feb
34K
Mar
31K
Apr
38K
May
42K
Jun

Why pharma companies choose MERACO

Maximize Governorate Penetration

Target the highest-yielding markets. View sales volume and market share variations across all 18 governorates to deploy distribution and sales teams where demand is highest.

100% data anonymization

All proprietary brand names in raw POS uploads are securely anonymized using local XOR encryption keys, ensuring compliant telemetry aggregation.

Real-Time Sales Velocity Tracking

Track immediate sale and procurement telemetry streams from connected terminals, allowing you to gauge brand velocity and demand trends.

Enterprise Access

Simple, unified pharma intelligence

Get full, unrestricted access to the entire platform. No hidden fees, no multiple tiers, just one enterprise license for your entire organization.

Full Platform License

All-Inclusive Pass

Full access to 18 governorates, pricing, and launch analytics

$1,000/ 6 months
Get Active License

Included Enterprise Benefits:

  • Market Overview & Live KPIs
  • Market Share Analytics
  • Financial Margin Auditing
  • Advanced Reports Generation
  • Pricing Intelligence comparison
  • Product Launch Feasibility study
  • AI Drug Name Normalization
  • Unlimited User accounts
  • 24/7 dedicated support
  • Secure live database sync